Mario Sobrino
Family Medicine · Kissimmee, FLNPI 1154497345
Payments from drug & device makers
Across 267 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$586
- Amarin Pharma, Inc.$560
- AstraZeneca$550
- Novo Nordisk$539
- Johnson & Johnson$427
- Lilly USA, LLC$322
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,733100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 24 | $586 |
| Amarin Pharma, Inc. | 40 | $560 |
| AstraZeneca | 32 | $550 |
| Novo Nordisk | 30 | $539 |
| Johnson & Johnson | 23 | $427 |
| Lilly USA, LLC | 19 | $322 |
| GSK | 20 | $306 |
| Boehringer Ingelheim | 15 | $276 |
| Pfizer | 13 | $227 |
| Novartis | 13 | $222 |
| Edwards Lifesciences | 2 | $71 |
| Exact Sciences | 3 | $65 |
| Viiv Healthcare Company | 4 | $64 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Abbott | 3 | $54 |
| Corcept Therapeutics | 2 | $46 |
| Sanofi-aventis U.S. LLC | 3 | $37 |
| EMD Serono, Inc. | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Cipher Pharmaceuticals US LLC | 1 | $29 |
| AbbVie | 1 | $27 |
| Radius Health, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Recordati_rare_diseases_inc. | 1 | $21 |
| Amgen | 1 | $17 |
| Merck | 1 | $15 |
| Biogen | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$4,733 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 32 | $33,233 |
| TrulicityDulaglutide | 19 | $23,903 |
| EliquisApixaban | 24 | $22,697 |
| FarxigaDapagliflozin Propanediol | 24 | $15,400 |
| JanuviaSitagliptin Phosphate | 12 | $9,919 |
| Atorvastatin Calcium | 152 | $1,312 |
| Losartan Potassium | 120 | $1,174 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $853 |
| Levothyroxine Sodium | 77 | $787 |
| Gabapentin | 48 | $771 |
| Rosuvastatin Calcium | 61 | $768 |
| Carvedilol | 45 | $597 |
| Metformin Hcl | 104 | $532 |
| Famotidine | 42 | $479 |
| Memantine Hcl | 19 | $446 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $276 | $33,23332 claims |
| Lilly USA, LLCTrulicity | $322 | $23,90319 claims |
| PfizerEliquis | $227 | $22,69724 claims |
| AstraZenecaFarxiga | $550 | $15,40024 claims |
| MerckJanuvia | $15 | $9,91912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Kissimmee
- Craig CurtisKissimmee$14.2M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.